Clear blue water for Avastin in third ovarian cancer study
08 February 2011
Alex Shimmings
Please Login to read the full article.
08 February 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US filing for Avastin in first-line ovarian cancer 'unlikely' despite European nod
- US Capitol Capsule: Hope not enough for Avastin in MBC; Hamburg explains withdrawal
- FDA staff argue Avastin benefit in breast cancer not worth the risk
- OCEANS data add weight to Roche case for Avastin in ovarian cancer
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
